| Boehringer Ingelheim (Schweiz) GmbH - Sifrol ER 4,5 mg, Retardtabletten |
| 60057 | | 05 | | Sifrol ER 4,5 mg | | Retardtabletten | | N04BC05 | | Pramipexole | | 10.06.2010 | | |
|
| Composition |
| pramipexoli dihydrochloridum monohydricum 4.500 mg corresp. pramipexolum 3.146 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 4.5 mg correspond Pramipexol 3.146 mg |
| | BAG: Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 4.5 mg |
| | | | Inactive agents | Dose |
|---|
| Carbomer | 941 | | Hypromellosum | | | Magnesii Stearas pro Compresso | | | Maydis Amylum | | | Silica Colloidalis Anhydrica | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 30 Tablet(s) | 165.09 | 194.45 | B | SL | Yes |
|
